Agfa board denies rumors of selling healthcare unit

  The Agfa-Gevaert board of directors today stated that “no decision has been taken to launch a process for the sale of the healthcare business group.”

The board said that they felt the need to make a public statement due to a number of articles have appeared in the Belgian press in the past week. The articles have stated that Agfa is about to launch a formal sales process for its healthcare business group, the company said.

In its regular meeting of today, the board took note of “the confusion created by this misleading information and therefore has decided to set the record straight.”

Agfa’s board also confirmed “its commitment to the preservation of the unity of the HealthCare business group, to its strategy and to the investments made for extending its leading position in healthcare IT.”

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.